Skip to main content

Our Clients

We have worked with over 2000 companies, investors and research institutions.

All clients, by client group

  • Alliance Foundation Trials, LLC
  • Bluefield Project to Cure FTD
  • Commonwealth Cancer Consortium (Break Through Cancer)
  • Cure GM1 Foundation
  • Global Alliance for TB Drug Development
  • Partners In Health
Learn more about our work in this industry

  • Ambulomics, Inc.
  • Arcaea, LLC
  • Day Zero Diagnostics, Inc.
  • Dialco Medical Inc.
  • Discovery Life Sciences, LLC
  • GelMEDIX, Inc.
  • hearX Group (Pty) Ltd.
  • HighRes Biosolutions, Inc.
  • Instylla, Inc.
  • Occlutech International AB
  • Palette Life Sciences AB
  • Presympto, Inc.
  • Proof Diagnostics Inc.
  • Savran Technologies Inc.
  • Sirtex Technology Pty Ltd
  • Spectral Medical Inc.
  • Tides Medical LLC
  • Vizgen, Inc.
Learn more about our work in this industry

  • Abata Therapeutics, Inc.
  • Actithera, Inc.
  • Adrenas Therapeutics, Inc.
  • Aerium Therapeutics, Inc.
  • Affini-T Therapeutics, Inc.
  • Affinia Therapeutics, Inc.
  • Affinivax, Inc.
  • Akouos, Inc.
  • Aldeyra Therapeutics, Inc.
  • Aliada Therapeutics, Inc.
  • Allorion Therapeutics Inc.
  • Allyx Therapeutics, Inc.
  • Alpheus Medical, Inc.
  • AmbAgon Therapeutics, Inc.
  • Ananda Scientific, Inc.
  • Anebulo Pharmaceuticals, Inc.
  • Anokion US, Inc.
  • Anthos Therapeutics, Inc.
  • Antidote Therapeutics, Inc.
  • AnTolRx, Inc.
  • Apic Bio, Inc.
  • Arbor Biotechnologies, Inc.
  • Arsanis Therapeutics
  • Artax Biopharma, Inc.
  • AS2 Bio, LLC
  • AsclepiX Therapeutics, Inc.
  • Aspa Therapeutics, Inc.
  • Astria Therapeutics, Inc.
  • Atavistik Bio
  • aTyr Pharma, Inc.
  • Aura Biosciences, Inc.
  • Auron Therapeutics, Inc.
  • Auxolytic, Ltd.
  • AvenCell Therapeutics, Inc.
  • Avenge Bio, Inc.
  • Axial Therapeutics, Inc.
  • Beam Therapeutics, Inc.
  • Bicara Therapeutics Inc.
  • BioSynapse, Inc.
  • Blue Oak Pharmaceuticals, Inc.
  • Bridge Biotherapeutics Inc.
  • BridgeBio Pharma
  • Carbon Biosciences, Inc.
  • Cardurion Pharmaceuticals, Inc.
  • Catamaran Bio, Inc.
  • Cedilla Therapeutics, Inc.
  • CG Pharmaceuticals, Inc.
  • Claris Biotherapeutics, Inc.
  • Clear Creek Bio, Inc.
  • Clover Key Bioscience, Inc.
  • Cogent Biosciences, Inc.
  • Cora Biosciences, Inc.
  • Corner Therapeutics, Inc.
  • Cybrexa, Inc.
  • Cyteir Therapeutics, Inc.
  • DEM BioPharma, Inc.
  • DermBiont, Inc.
  • Dianthus Therapeutics, Inc.
  • Diceros Therapeutics, Inc.
  • Disc Medicine, Inc.
  • Editas Medicine, Inc.
  • Eicosis LLC
  • Elevian, Inc.
  • Elicio Therapeutics, Inc.
  • Epalex Corporation
  • Epibiologics, Inc.
  • Ernest Pharmaceuticals, LLC
  • Eumentis Therapeutics, Inc.
  • EvolveImmune Therapeutics, Inc.
  • Expansion Therapeutics, Inc.
  • Flare Therapeutics
  • FOG Pharmaceuticals, Inc.
  • Forma Therapeutics, Inc.
  • General Oncology, Inc.
  • Generate Biomedicines
  • GV.M1 Inc.
  • GV20 Therapeutics LLC
  • Hatch Therapeutics, Inc.
  • hC Bioscience, Inc.
  • HilleVax, Inc
  • Holobiome, Inc.
  • HotSpot Therapeutics, Inc.
  • Huya Bioscience International, LLC
  • IDBiologics, Inc.
  • IDEAYA Biosciences, Inc.
  • Ikena Oncology, Inc.
  • ImmunoGen, Inc.
  • Infinity Pharmaceuticals, Inc.
  • Intergalactic Therapeutics, Inc
  • iOmx Therapeutics AG
  • Ipsen Bioscience Inc.
  • iTeos Therapeutics, Inc.
  • Jounce Therapeutics, Inc.
  • KalVista Pharmaceuticals, Inc.
  • Kantum Pharma, Inc.
  • Kanyos Bio, Inc.
  • Kirilys Therapeutics, Inc.
  • KSQ Therapeutics, Inc.
  • Kymera Therapeutics, Inc.
  • Launchpad Therapeutics, Inc.
  • Lexeo Therapeutics, Inc.
  • Lyra Therapeutics, Inc.
  • Magnet Biomedicine, Inc.
  • Mariana Oncology
  • MarPam Pharma, LLC
  • MediBeacon Inc.
  • Merlin Therapeutics, Inc.
  • Mnemo Therapeutics SAS
  • Molecular Templates, Inc.
  • Moment Bio, Inc.
  • MorphoSys AG
  • Myeloid Therapeutics, Inc.
  • Mythic Therapeutics, Inc.
  • Neomorph, Inc.
  • Neurogastrx, Inc.
  • NextPoint Therapeutics, Inc.
  • NextRNA Therapeutics, Inc.
  • Normunity AccelCo, Inc.
  • Normunity, Inc.
  • NorthSea Therapeutics, B.V.
  • Nurix Therapeutics, Inc.
  • Obsidian Therapeutics, Inc.
  • Okava Pharmaceuticals, Inc.
  • Olaris Inc.
  • Oligomerix, Inc.
  • Omega Therapeutics, Inc.
  • Oncorus, Inc.
  • ONK Therapeutics Limited
  • Orna Therapeutics, Inc.
  • PanOptica, Inc.
  • Paragon Therapeutics, Inc.
  • Parthenon Therapeutics, Inc.
  • Pathalys Pharma, Inc.
  • PepGen Inc.
  • Peptilogics, Inc.
  • perForm biologics, inc.
  • Phenex Pharmaceuticals AG
  • Photys, Inc.
  • Phylaxis Bioscience, LLC
  • PIC Therapeutics, Inc.
  • Pinetree Therapeutics, Inc.
  • Praeventix, Inc.
  • ProThera Biologics, Inc.
  • Q1, Inc.
  • QurAlis Corporation
  • Regenacy Pharmaceuticals, Inc.
  • Rekindle Therapeutics Inc.
  • Relay Therapeutics, Inc.
  • RemeGen Biosciences, Inc.
  • Repare Therapeutics, Inc.
  • Revalia Bio, Inc.
  • Rhoshan Pharmaceuticals, Inc.
  • Right Brain Bio, Inc.
  • Rila Therapeutics, Inc.
  • Rizana Therapeutics, Inc.
  • SalioGen Therapeutics, Inc.
  • Schrödinger, Inc.
  • Scorpion Therapeutics, Inc.
  • Seal Rock Therapeutics, Inc.
  • Seismic Therapeutic, Inc.
  • Senda Biosciences, Inc.
  • Sionna Therapeutics, Inc.
  • Sojournix, Inc.
  • SonALAsense, Inc.
  • Sonnet BioTherapeutics, Inc.
  • SOTIO Biotech Inc.
  • Souffle Therapeutics
  • Spruce Biosciences, Inc.
  • Spyre Therapeutics, Inc.
  • STORM Therapeutics Ltd.
  • Strand Therapeutics, Inc.
  • Summation Bio, Inc.
  • Surface Oncology, Inc.
  • SURGE Therapeutics, Inc.
  • Syndax Pharmaceuticals, Inc.
  • Synedgen, Inc.
  • Syros Pharmaceuticals, Inc.
  • T-knife Therapeutics, Inc.
  • Tasca Therapeutics Corp.
  • Tavanta Therapeutics, Inc.
  • Tectonic Therapeutic, Inc.
  • Telavant, Inc.
  • Teneobio, Inc.
  • Tessera Therapeutics, Inc.
  • Theaprin Pharmaceuticals, Inc.
  • Theragnostics Ltd.
  • TransformaTX Biotherapeutics LLC
  • Transition Bio, Inc.
  • Treadwell Therapeutics, Inc.
  • Vedere Bio, Inc.
  • Vernal Biosciences, Inc.
  • Verra Therapeutics, LLC
  • Versatope Therapeutics, Inc.
  • Verseau Therapeutics, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Vertical Bio AG
  • Verve Therapeutics, Inc.
  • Vigil Neuroscience, Inc.
  • Viridian Therapeutics, Inc.
  • Viridian, LLC
  • Volastra Therapeutics, Inc.
  • Volstra Therapeutics
  • Wade Biomedicines Inc.
  • Walking Fish Therapeutics, Inc.
  • Xbiome, Inc.
  • Xellar, Inc.
  • XenImmune Therapeutics, Inc.
  • Zenas BioPharma
  • Zenon Biotech, Inc.
Learn more about our work in this industry

  • 143 Studios Inc.
  • Advanced Development Methods, Inc.
  • Artha Networks, Inc.
  • Clisertec Corporation
  • Curated Planet, LLC
  • Dexai Robotics, Inc
  • Gleason Technology, Inc.
  • GOLDPoint Healthcare, LLC
  • IQ Proteomics, LLC
  • Liteboxer Technologies, Inc.
  • Mel Robbins Productions, Inc.
  • Muzooka, Inc.
  • Optera Life Sciences, LLC
  • Parking Edge LLC
  • Sibyl Analytics, LLC
  • YBRP, Inc.
Learn more about our work in this industry

  • .406 Ventures
  • 4D Molecular Therapeutics, Inc.
  • 5AM Venture Management LLC
  • 6 Dimensions Capital
  • AllerFund Ventures, LLC
  • Arch Venture Fund XII
  • Atlas Venture
  • CBT Advisors
  • CoVenture
  • Cure Ventures Management, L.P.
  • Epidarex Management, Ltd.
  • Flagship Pioneering
  • GG1978 SICAF SIF
  • Gimv NV
  • GV Management Company, LLC
  • Hutchison MediPharma Limited
  • Ross Equity Partners, L.P.
  • Soffer Holdings LLC
  • U.S. Equity Holdings, LLC
  • Versant Ventures Management, LLC
Learn more about our work in this industry

Recent transactions

Previous Page
Next Page
NextPoint Therapeutics, Inc. Logo

NextPoint Therapeutics, Inc.

Series B Financing - $80 million

NextPoint Therapeutics raises $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.  Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. Existing investors that took part in the financing include MPM Capital Management and Dana-Farber Cancer Institute

6 Dimensions Capital Logo

6 Dimensions Capital

VC Investments

Equity investments in multiple portfolio companies, including Hibercell

Puma Biotechnology, Inc. Logo

Puma Biotechnology, Inc.

Clinical Trial

CRO and Site Agreements for an Open-Label, Phase 2 Study with 30 Sites in 9 Countries exploring the efficiency of Neratinib on Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations Or EGFR Gene Amplification

See Study
Epalex Corporation Logo

Epalex Corporation

Series A-3 Financing

Series A-3 preferred equity financing to continue advancing Epalex’s two clinical-stage development programs

Praeventix, Inc. Logo

Praeventix, Inc.

Private Investment

Private Investment from Tellus BioVentures

Vertex Pharmaceuticals Incorporated Logo

Vertex Pharmaceuticals Incorporated

Acquisition of Private Company

Co-counsel to Vertex on acquisition of ViaCyte, a privately-held biotechnology company that received substantial research funding from the California Institute of Regenerative Medicine

Press Release
Versant Ventures Management, LLC Logo

Versant Ventures Management, LLC

Antibody Discovery and Collaboration Agreement

Multi-year collaboration with AbCellera to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechnology companies

Press Release
Vizgen, Inc. Logo

Vizgen, Inc.

Series C Financing

Vizgen raises Series C equity funding led by Blue Water Life Science Advisors, LLC, ARCH Venture Fund X, L.P. and other existing investors

Press Release
Vernal Biosciences, Inc. Logo

Vernal Biosciences, Inc.

Series A Financing

Vernal Biosciences raises $21M Series A equity funding led by Dynamk Life Sciences Fund, L.P., Charles River Laboratories, Inc. and Ampersand 2020 Limited Partnership

Press Release
Artax Biopharma, Inc. Logo

Artax Biopharma, Inc. + Advent Life Sciences Fund II LP

Series B Financing (Series B4)

Artax Biopharma raises Series B-4 round of equity funding led by Advent Life Sciences Fund II LP, Advent Life Sciences LLP, Columbus Life Science Fund II, FCR, Hiyuli Ventures Limited, Belinda A. Termeer, and other existing investors, plus new investors including Sound Bioventures Fund I AB and and Eli Lilly

Press Release
Dianthus Therapeutics, Inc. Logo

Dianthus Therapeutics, Inc.

Series A Financing

Dianthus raises $100 million Series A financing led by 5AM Ventures, Fidelity Management & Research Company, Avidity Partners, Venrock, Fairmount Funds, Tellus BioVentures and other investors

Press Release
Summation Bio, Inc. Logo

Summation Bio, Inc.

Series A Financing

Summation Bio raises Series A equity funding led by RA Capital Healthcare Fund, L.P., RA Capital NEXUS Fund, L.P., RA Capital NEXUS Fund III, L.P., Blackwell Partners LLC and other existing investors

This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.